CVS HEALTH CORPORATION Share-based Payment Arrangement, Expense
CVS HEALTH CORPORATION (CVS) reported Share-based Payment Arrangement, Expense of $535.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-02-10
- CVS HEALTH CORPORATION share-based payment arrangement, expense for the quarter ending 2018-12-31 was $108.00M, a 77.05% increase year-over-year.
- CVS HEALTH CORPORATION share-based payment arrangement, expense for the quarter ending 2018-09-30 was $62.00M, a 4.62% decline year-over-year.
- CVS HEALTH CORPORATION share-based payment arrangement, expense for the quarter ending 2018-06-30 was $54.00M, a 1.89% increase year-over-year.
- CVS HEALTH CORPORATION share-based payment arrangement, expense for the quarter ending 2017-12-31 was $61.00M, a 8.93% increase year-over-year.
- CVS HEALTH CORPORATION share-based payment arrangement, expense for fiscal 2025 was $535.00M, a 0.93% decline from fiscal 2024.
- CVS HEALTH CORPORATION share-based payment arrangement, expense for fiscal 2024 was $540.00M, a 8.16% decline from fiscal 2023.
- CVS HEALTH CORPORATION share-based payment arrangement, expense for fiscal 2023 was $588.00M, a 31.54% increase from fiscal 2022.
- CVS HEALTH CORPORATION share-based payment arrangement, expense for fiscal 2022 was $447.00M, a 7.64% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $535.00M 10-K · filed 2026-02-10 | |||
| 2024-12-31 | $540.00M 10-K · filed 2026-02-10 | |||
| 2023-12-31 | $588.00M 10-K · filed 2026-02-10 | |||
| 2022-12-31 | $447.00M 10-K · filed 2025-02-12 | |||
| 2021-12-31 | $484.00M 10-K · filed 2024-02-07 | |||
| 2020-12-31 | $400.00M 8-K · filed 2023-05-25 | |||
| 2019-12-31 | $453.00M 10-K · filed 2022-02-09 | |||
| 2018-12-31 | $108.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $170.00M derived: sum of 2 quarters · filed 2021-02-16 | $224.00M derived: sum of 3 quarters · filed 2021-02-16 | $280.00M 10-K · filed 2021-02-16 |
| 2018-09-30 | $62.00M 10-Q · filed 2018-11-06 | $116.00M derived: sum of 2 quarters · filed 2018-11-06 | $172.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $54.00M 10-Q · filed 2018-08-08 | $110.00M 10-Q · filed 2018-08-08 | ||
| 2017-12-31 | $61.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $126.00M derived: sum of 2 quarters · filed 2020-02-18 | $179.00M derived: sum of 3 quarters · filed 2020-02-18 | $234.00M 10-K · filed 2020-02-18 |
| 2017-09-30 | $65.00M 10-Q · filed 2018-11-06 | $118.00M derived: sum of 2 quarters · filed 2018-11-06 | $173.00M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $53.00M 10-Q · filed 2018-08-08 | $108.00M 10-Q · filed 2018-08-08 | ||
| 2016-12-31 | $56.00M derived: 8-K 12 month − 10-Q 9 month · filed 2019-08-08 | $114.00M derived: sum of 2 quarters · filed 2019-08-08 | $164.00M derived: sum of 3 quarters · filed 2019-08-08 | $222.00M 8-K · filed 2019-08-08 |
| 2016-09-30 | $58.00M 10-Q · filed 2017-11-06 | $108.00M derived: sum of 2 quarters · filed 2017-11-06 | $166.00M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | $50.00M 10-Q · filed 2017-08-08 | $107.00M 10-Q · filed 2017-08-08 | ||
| 2015-12-31 | $55.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $142.00M derived: sum of 2 quarters · filed 2018-02-14 | $186.00M derived: sum of 3 quarters · filed 2018-02-14 | $230.00M 10-K · filed 2018-02-14 |
| 2015-09-30 | $87.00M 10-Q · filed 2016-11-08 | $131.00M derived: sum of 2 quarters · filed 2016-11-08 | $175.00M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $44.00M 10-Q · filed 2016-08-02 | $88.00M 10-Q · filed 2016-08-02 | ||
| 2014-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $88.00M derived: sum of 2 quarters · filed 2017-02-09 | $130.00M derived: sum of 3 quarters · filed 2017-02-09 | $165.00M 10-K · filed 2017-02-09 |
| 2014-09-30 | $44.00M 10-Q · filed 2015-10-30 | $86.00M derived: sum of 2 quarters · filed 2015-10-30 | $121.00M 10-Q · filed 2015-10-30 | |
| 2014-06-30 | $42.00M 10-Q · filed 2015-08-04 | $77.00M 10-Q · filed 2015-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |